Orpea SA (ORPEF)
USD 14.22
(848.0%)
USD 14.22
(848.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 109.11 Million EUR | -80.36% |
| 2022 | 613.14 Million USD | 720.7% |
| 2021 | -98.78 Million USD | -342.8% |
| 2020 | 40.68 Million USD | -61.83% |
| 2019 | 106.58 Million USD | -7.28% |
| 2018 | 114.96 Million USD | -10.91% |
| 2017 | 129.03 Million USD | 24.82% |
| 2016 | 103.38 Million USD | 16.82% |
| 2015 | 88.49 Million USD | 29.05% |
| 2014 | 68.57 Million USD | -39.84% |
| 2013 | 114 Million USD | 20.54% |
| 2012 | 94.57 Million USD | 17.46% |
| 2011 | 80.52 Million USD | 18.35% |
| 2010 | 68.03 Million USD | 0.18% |
| 2009 | 67.91 Million USD | 23.24% |
| 2008 | 55.1 Million USD | 21.32% |
| 2007 | 45.42 Million USD | 43.06% |
| 2006 | 31.75 Million USD | 22.82% |
| 2005 | 25.85 Million USD | 40.99% |
| 2004 | 18.33 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 23.56 Million USD | -74.17% |
| 2023 Q4 | 91.24 Million USD | 216.33% |
| 2023 Q1 | 196.32 Million EUR | -46.96% |
| 2023 Q3 | 856.86 Million EUR | 3140.18% |
| 2023 FY | 109.11 Million EUR | -97.52% |
| 2023 Q2 | 28.84 Million USD | -92.72% |
| 2022 FY | 4.4 Billion EUR | 42.65% |
| 2022 Q4 | 396.13 Million USD | 45.23% |
| 2022 Q3 | 2.22 Billion EUR | 755.47% |
| 2022 Q1 | 275.47 Million EUR | 302621.43% |
| 2022 Q2 | 272.76 Million USD | 263605.23% |
| 2021 Q4 | 103.43 Thousand USD | -99.41% |
| 2021 FY | 3.08 Billion EUR | 12.43% |
| 2021 Q2 | 17.51 Million USD | 132.18% |
| 2021 Q3 | 193.87 Million EUR | 1212.56% |
| 2021 Q1 | 110.24 Million EUR | 1688.01% |
| 2020 Q2 | 30.42 Million USD | -37.16% |
| 2020 FY | 2.74 Billion EUR | 9.07% |
| 2020 Q1 | 133.67 Million EUR | 209.92% |
| 2020 Q4 | 7.54 Million USD | -75.2% |
| 2020 Q3 | 164.39 Million EUR | 506.95% |
| 2019 Q3 | 163.16 Million EUR | 214.84% |
| 2019 Q1 | 133.03 Million EUR | 84.13% |
| 2019 FY | 2.51 Billion EUR | 21.16% |
| 2019 Q2 | 59.01 Million USD | 42.82% |
| 2019 Q4 | 48.41 Million USD | -17.97% |
| 2018 Q4 | 41.32 Million USD | -45.06% |
| 2018 Q3 | 72.24 Million EUR | 3.09% |
| 2018 Q2 | 75.21 Million USD | 22.21% |
| 2018 Q1 | 70.08 Million EUR | -9.2% |
| 2018 FY | 2.07 Billion EUR | 9.39% |
| 2017 Q1 | 117.7 Million EUR | 289.55% |
| 2017 FY | 1.9 Billion EUR | 12.32% |
| 2017 Q3 | 77.17 Million EUR | -34.43% |
| 2017 Q4 | 61.54 Million USD | -4.0% |
| 2017 Q2 | 64.1 Million USD | 22.63% |
| 2016 Q4 | 52.27 Million USD | 7.9% |
| 2016 FY | 1.69 Billion EUR | 21.27% |
| 2016 Q2 | 48.45 Million EUR | 0.0% |
| 2016 Q3 | 30.21 Million EUR | -47.03% |
| 2016 Q1 | 57.03 Million EUR | -0.3% |
| 2015 Q3 | 57.21 Million EUR | 5.97% |
| 2015 Q4 | 57.21 Million EUR | 0.0% |
| 2015 FY | 1.39 Billion EUR | 23.99% |
| 2015 Q1 | 53.98 Million EUR | 37.05% |
| 2015 Q2 | 53.98 Million EUR | 0.0% |
| 2014 Q1 | 48.9 Million EUR | 24.72% |
| 2014 FY | 1.12 Billion EUR | 18.06% |
| 2014 Q4 | 39.39 Million EUR | 0.0% |
| 2014 Q3 | 39.39 Million EUR | -19.46% |
| 2014 Q2 | 48.9 Million EUR | 0.0% |
| 2013 Q2 | 35.15 Million EUR | 0.0% |
| 2013 Q4 | 39.21 Million EUR | 0.0% |
| 2013 FY | 952.99 Million EUR | 11.65% |
| 2013 Q1 | 35.15 Million EUR | 0.0% |
| 2013 Q3 | 39.21 Million EUR | 11.54% |
| 2012 FY | 853.57 Million EUR | 15.81% |
| 2011 FY | 737.06 Million EUR | 26.54% |
| 2010 FY | 582.48 Million EUR | 14.61% |
| 2009 FY | 508.24 Million EUR | 20.44% |
| 2008 FY | 422 Million EUR | 32.45% |
| 2007 FY | 318.62 Million EUR | 25.95% |
| 2006 FY | 252.98 Million EUR | 35.83% |
| 2005 FY | 186.25 Million EUR | 34.81% |
| 2004 FY | 138.15 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| The Amacore Group, Inc. | 64.06 Million USD | -70.307% |
| Arem Pacific Corporation | 367.08 Thousand USD | -29624.583% |
| Assisted 4 Living, Inc. | 833.9 Thousand USD | -12984.584% |
| BioCorRx Inc. | 3.84 Million USD | -2740.767% |
| Bionik Laboratories Corp. | 5.81 Million USD | -1776.433% |
| Banyan Corp. | 6.59 Million USD | -1553.836% |
| Clearday, Inc. | 5 Million USD | -2081.073% |
| Dental Patient Care America, Inc. | 3.27 Million USD | -3230.82% |
| Quantum Medical Transport, Inc. | 874.76 USD | -12473378.44% |
| Empower Clinics Inc. | 6.92 Million USD | -1476.245% |
| First Choice Healthcare Solutions, Inc. | 2.44 Million USD | -4371.084% |
| Selectis Health, Inc. | 14.36 Million USD | -659.441% |
| Ethema Health Corporation | 5.27 Million USD | -1969.63% |
| HealthLynked Corp. | 9.73 Million USD | -1021.225% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.43 Million USD | -1055.983% |
| JRSIS Health Care Corporation | 671.64 Thousand USD | -16145.539% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 75.35 Million USD | -44.793% |
| MedSmart Group Inc. | 65.47 Thousand USD | -166558.521% |
| North America Frac Sand, Inc. | 775.75 Thousand USD | -13965.394% |
| Nova Leap Health Corp. | 9.3 Million USD | -1072.221% |
| Nexteligent Holdings, Inc. | 553.38 Thousand USD | -19617.233% |
| PAO Group, Inc. | 45.42 Thousand USD | -240131.176% |
| Primemd Inc. | 6.25 Million USD | -1643.61% |
| Raffles Medical Group Ltd | 151.69 Million USD | 28.069% |
| Ryman Healthcare Limited | 9.61 Million USD | -1035.052% |
| Stem Cell Authority, Ltd. | 4233.00 USD | -2577575.408% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.38 Million USD | -7802.313% |
| Mycotopia Therapies, Inc. | 616.72 Thousand USD | -17592.355% |
| U.S. NeuroSurgical Holdings, Inc. | 765 Thousand USD | -14163.137% |
| Veltex Corporation | 1.77 Million USD | -6039.909% |
| World Financial Holding Group | 28.42 Thousand USD | -383749.293% |
| Xcelerate Inc. | 2.9 Million USD | -3653.737% |